Calibre Scientific has acquired UK-based Lorne Laboratories, a specialty manufacturer of blood grouping reagents and diagnostic test kits, and a distributor of related laboratory equipment, enzymes and biochemical.
Lorne’s catalogue services governments, blood transfusion professionals, and hospital laboratories in over 100 countries, and is an established critical partner of the UK’s National Health Service.
“Blood typing is critical to the medical field, ensuring the safety of recipients during blood transfusions,” said Dr Mike Brownleader. “Calibre Scientific has made the support of COVID research efforts a priority on a global scale. With more of our partners sharing an interest in the clinical and medical segments of life science, we believe Lorne’s specialisation in blood grouping reagents will be a key addition to our growing core diagnostics catalogue.”
Eddy Velthuis (Chief Technical Officer at Lorne Laboratories) said: “Lorne has always endeavoured to, and succeeded in, providing the highest quality blood grouping reagents that comply with all necessary regulatory requirements. We’re excited to join forces with a premier life sciences company in Calibre Scientific to expand our reach and offerings.”
Ben Travis (CEO of Calibre Scientific) said: “World-class quality and customer satisfaction have established Lorne as a reliable partner to their customers and the medical community at large. These same principles are at the core of our business. With the addition of Lorne, we will bolster our diagnostics division and expand our expertise. It is our aspiration to uphold Lorne’s high standards and lift them even higher as we incorporate them into our global team.”
